Literature DB >> 2954651

Alternative splicing of E1A transcripts of adenovirus requires appropriate ionic conditions in vitro.

P Schmitt, R Gattoni, P Keohavong, J Stévenin.   

Abstract

We have developed an in vitro splicing system using a HeLa cell nuclear extract that is highly active for the alternative splicing of the natural E1A transcripts. The efficiency of using the three alternative 5' splice sites is strongly dependent on the ionic conditions in the reaction, and the simultaneous production of the 13S, 12S, and 9S mRNA species is observed only at appropriate salt concentrations. All the intermediate and final splicing products have been extensively characterized and it has been demonstrated that the same major branch site is used for all the alternative reactions. The ratio of 13S to 9S mRNAs formed is close to that observed in vivo early in infection, suggesting that most of the mechanisms giving rise to alternative splicing are preserved in vitro.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2954651     DOI: 10.1016/0092-8674(87)90659-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  35 in total

1.  Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.

Authors:  C F Bourgeois; M Popielarz; G Hildwein; J Stevenin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers.

Authors:  Y Cavaloc; C F Bourgeois; L Kister; J Stévenin
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

3.  The RNA-binding protein TIA-1 is a novel mammalian splicing regulator acting through intron sequences adjacent to a 5' splice site.

Authors:  F Del Gatto-Konczak; C F Bourgeois; C Le Guiner; L Kister; M C Gesnel; J Stévenin; R Breathnach
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Regulated adenovirus mRNA 3'-end formation in a coupled in vitro transcription-processing system.

Authors:  S I Wilson-Gunn; J E Kilpatrick; M J Imperiale
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

5.  Multiple activities of the human splicing factor ASF.

Authors:  J E Harper; J L Manley
Journal:  Gene Expr       Date:  1992

6.  The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.

Authors:  Vita Dauksaite; Göran Akusjärvi
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

7.  A novel protein factor is required for use of distal alternative 5' splice sites in vitro.

Authors:  J E Harper; J L Manley
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

8.  Differential block of U small nuclear ribonucleoprotein particle interactions during in vitro splicing of adenovirus E1A transcripts containing abnormally short introns.

Authors:  M Himmelspach; R Gattoni; C Gerst; K Chebli; J Stévenin
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

9.  Model for tissue specific Calcitonin/CGRP-I RNA processing from in vitro experiments.

Authors:  R A Bovenberg; G J Adema; H S Jansz; P D Baas
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

10.  Unusual branch point selection involved in splicing of the alternatively processed Calcitonin/CGRP-I pre-mRNA.

Authors:  G J Adema; R A Bovenberg; H S Jansz; P D Baas
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.